Compare Mitra Investindo Tbk. (MITI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Investindo Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra Investindo Tbk. trades at Rp286 (market cap 862.62B, 78.12M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitra Investindo Tbk. is far larger — about 8.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MITI | SCPI | |
|---|---|---|
Market Cap | 862.62B | 104.4B |
Volume | 78.12M | — |
Lot | 781.23K | — |
Turnover | 21.33B | — |
Average Price | 272.98 | — |
Value | 21.33B | — |
Indicative Equilibrium Price | 286 | — |
Indicative Equilibrium Volume | 531 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Investindo Tbk.
PT Mitra Investindo Tbk (the Company) was established based on notarial deed No. 280 dated 16 September 1993 of Misahardi Wilamarta, S.H., notary in Jakarta, under the name of PT Minsuco International Finance. The Company's Articles of Association was amended several times, which one of the amendments was based on notarial deed No. 10 dated 15 March 2006 of Amrul Partomuan Pohan, S.H., llm., Notary in Jakarta, concerning the merger of PT Siwani Trinitra Tbk with PT Caraka Berkat Sarana to become PT Mitra Investindo Tbk.
Read more on MITI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
